Where is Axtria headquartered?

Axtria is headquartered in Berkeley Heights, USA. The company has a team of 1001-5000 people.

Axtria operates in the AI in Healthcare sector. Axtria is a global provider of cloud software and data analytics for the life sciences industry, enabling them to transform their product commercialization journey. To help life sciences companies drive sales growth and improve healthcare outcomes by leveraging AI-driven data analytics and software to transform their commercial operations.

When was Axtria founded?

Axtria was founded in 2010. It is based in Berkeley Heights, USA.

Who is the CEO of Axtria?

Jaswinder Chadha is the CEO of Axtria. The company was founded in 2010.

Where is Axtria located?

Axtria is headquartered in Berkeley Heights, USA.

What funding stage is Axtria at?

Axtria is currently at the Growth Stage stage.

How many employees does Axtria have?

Axtria has approximately 1001-5000 employees.

Axtria

Category: AI in Healthcare

Axtria is a global provider of cloud software and data analytics for the life sciences industry, enabling them to transform their product commercialization journey. Axtria was founded in 2010. The company is led by Jaswinder Chadha. Based in Berkeley Heights, USA. Team size: 1001-5000. Total funding raised: $439.3M. Latest round: Series E. Key investors include Bain Capital Tech Opportunities, Kedaara Capital, Sequoia Capital, Helion Venture Partners.

Founded: 2010
Headquarters: Berkeley Heights, USA
Team size: 1001-5000
Total funding: $439.3M

Value proposition

To help life sciences companies drive sales growth and improve healthcare outcomes by leveraging AI-driven data analytics and software to transform their commercial operations.

Products and solutions

Axtria DataMAx™: A data management platform., Axtria SalesIQ™: A sales planning and operations platform., Axtria CustomerIQ™: An omnichannel customer engagement platform., Axtria MarketingIQ™: A marketing analytics and brand activation platform., Axtria InsightsMAx.ai: An enterprise-grade agentic AI platform with 30+ ready-to-deploy agents, apps, and APIs., CRM Services (via Conexus Solutions): End-to-end CRM transformation across Veeva and Salesforce ecosystems.

Unique value

Axtria's uniqueness lies in its deep domain expertise in the life sciences industry combined with its AI-first approach and integrated suite of cloud-based products. This allows them to provide end-to-end solutions for the entire commercialization process.

Target customer

Life sciences companies, including pharmaceutical, biotechnology, and medical device organizations.

Industries served

Life Sciences, Pharmaceuticals, Biotechnology, Medical Devices

Technology advantage

Axtria's key advantage is its ability to turn vast amounts of data into actionable insights through its AI and machine learning-powered platforms. This enables life sciences companies to make data-driven decisions, optimize their sales and marketing strategies, and improve patient outcomes.

How they differentiate

Axtria differentiates itself by offering an integrated, AI-powered platform specifically for the life sciences industry. This platform combines data management, analytics, and commercial operations to help clients accelerate the process of bringing therapeutics to market. Their focus is on providing end-to-end solutions from data to insights to operations, which contrasts with competitors who might specialize in only one part of the value chain.

Main competitors

ZS Associates, IQVIA, Veeva Systems

Key partnerships

Salesforce, Amazon Web Services (AWS), Reltio, Snowflake, Databricks

Notable customers

Works with 18 of the top 20 global pharmaceutical companies and 100+ firms across 75+ countries, A top-5 global pharma company, A leading global biopharmaceutical company, A mid-size pharmaceutical company

Major milestones

Founded in 2010., Secured a $150 million growth investment from Bain Capital Tech Opportunities in 2021., Achieved unicorn status with a valuation over $1 billion., Expanded global footprint with offices across the US, Europe, and India., Received a significant secondary investment of $240 million from Kedaara Capital in September 2025., Consistently recognized by industry analysts like Gartner and Everest Group for its life sciences commercial analytics and operations solutions., Launched Axtria InsightsMAx.ai, an enterprise-grade agentic AI platform with 30+ ready-to-deploy agents, in April 2025., Acquired Conexus Solutions in April 2026 to enter end-to-end CRM capabilities across Veeva and Salesforce ecosystems.

Growth metrics

As a private company, Axtria does not disclose specific growth metrics. However, its consistent high-value funding rounds, unicorn status, and expanding global operations indicate strong and sustained growth.

Market positioning

Axtria is positioned as a specialized leader in the life sciences data analytics and commercial excellence sector. It targets pharmaceutical, biotechnology, and medical device companies with a suite of cloud-based software products and related professional services, aiming to be a one-stop-shop for their commercialization needs.

Geographic focus

Axtria has a global focus, with its headquarters in the USA (Berkeley Heights, NJ) and a significant presence in North America, Europe, and Asia, including multiple offices in India.

Patents and IP

Information on specific patents is not publicly available. Axtria likely protects its intellectual property through trade secrets and software copyrights.

About Jaswinder Chadha

Co-founder and CEO of Axtria. Previously, he was the Co-founder and CEO of marketRx, which was acquired by Cognizant in 2007. After the acquisition, he led the Global Analytics Practice at Cognizant.

Official website: https://www.axtria.com